Form D · Biotechnology

Simergent, LLC

Oklahoma City, OK · CIK 0002021363

Offering snapshot reported Mar 27, 2026 · SEC filing

Reported sold
$8.84M
Offering amount: $9.86M
Investors reported
57
Form D · investor count
Minimum accepted
$18.4K
Reported outside-investor minimum
First sale
Mar 29, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.42M$8.84MMay 13, 2024: $7,801,331.00May 13, 2024Mar 27, 2026: $8,836,066.00Mar 27, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,801,331 → $8,836,066
  • Reported investors51 → 57

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 27, 2026Amendment$8,836,066$1,034,735vs May 13, 202457SEC filing
May 13, 2024Initial$7,801,331No comparison51SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-513117

Source: Form D, filed Mar 27, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve J Lindo Director, Executive
Rick Pendergraft Director, Executive
Michael Rohleder Director, Executive
Meredith Wilkerson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11 Ne 11 Th Street Suite 229
Oklahoma City, OK, 73104